Cargando…
PRE-ADMISSION ORAL ANTICOAGULATION IS ASSOCIATED WITH FEWER THROMBOTIC COMPLICATIONS IN PATIENTS ADMITTED WITH COVID-19
Autores principales: | Louis, David, Kennedy, Kevin, Saad, Marwan, Salber, Gregory, Imran, Hafiz Muhammad, Wark, Tyler, Soares, Cullen, Ghosalkar, Dhairyasheel, Cherala, Rasan, Poppas, Athena, Abbott, J. Dawn, Aronow, Herbert D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American College of Cardiology Foundation. Published by Elsevier Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8972565/ http://dx.doi.org/10.1016/S0735-1097(22)02789-9 |
Ejemplares similares
-
Preadmission Oral Anticoagulation for Atrial Fibrillation/Flutter and Death or Thrombotic Events During COVID-19 Admission
por: Louis, David W., et al.
Publicado: (2022) -
Preadmission Statin Treatment and Outcome in Patients Hospitalized With COVID-19
por: Saad, Marwan, et al.
Publicado: (2022) -
Cerebral vascular injury in transplant-associated thrombotic microangiopathy
por: Sabulski, Anthony, et al.
Publicado: (2022) -
Prior intake of new oral anticoagulants adversely affects outcome following surgery for acute type A aortic dissection
por: Sromicki, Juri, et al.
Publicado: (2022) -
Off‐target effects of oral anticoagulants – vascular effects of vitamin K antagonist and non‐vitamin K antagonist oral anticoagulant dabigatran etexilate
por: van Gorp, Rick H., et al.
Publicado: (2021)